Hikma Pharmaceuticals USA Inc.
Hikma Pharmaceuticals USA Inc. has 21 FDA recalls (2 Class I), 64 inspections, 0 510(k) clearances and 4 compliance actions on record.
- Latest recall
- D-0076-2027 · Class II · Oct 6, 2026
- Latest inspection
- Jul 13, 2026 · VAI
Reviewing Hikma Pharmaceuticals USA Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Hikma Pharmaceuticals USA Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 21 (2 Class I) | Nov 2, 2026 | File dated Oct 27, 2026 | Current |
| 510(k) clearances | 0 | Nov 2, 2026 | File dated Oct 30, 2026 | Current |
| Inspections | 64 | Nov 7, 2026 | Newest record Oct 28, 2026 | Current |
| Compliance actions | 4 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Related names
| Name | Recalls | 510(k) | Inspections | Compliance | Most recent recall |
|---|---|---|---|---|---|
| Hikma Pharmaceuticals | 0 | 0 | 5 | 0 | — |
| Hikma Cali | 0 | 0 | 1 | 0 | — |
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0076-2027 | Class II | Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma… | Oct 6, 2026 |
| D-0831-2026 | Class II | Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules… | Aug 24, 2026 |
| D-0526-2026 | Class II | Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr… | Apr 7, 2026 |
| D-0551-2025 | Class II | Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley… | Jul 22, 2025 |
| D-0635-2024 | Class I | Acetaminophen Injection, 1,000 mg per 100 mL (10 mg/mL), 100 mL Single Dose bags, For Intravenous… | Jul 8, 2024 |
| D-0392-2024 | Class II | Infumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured… | Mar 12, 2024 |
| D-0574-2023 | Class II | Lorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01), packaged in 25 x 1 mL Vials per… | May 11, 2023 |
| D-0090-2023 | Class II | Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by… | Dec 16, 2022 |
| D-1309-2022 | Class II | Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by… | Jul 11, 2022 |
| D-1310-2022 | Class II | Lorazepam Injection, USP, 4mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by… | Jul 11, 2022 |
| D-1308-2022 | Class II | Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per carton, RX Only… | Jul 11, 2022 |
| D-1307-2022 | Class II | Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by… | Jul 11, 2022 |
| D-0771-2021 | Class III | Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by… | Aug 5, 2021 |
| D-0169-2021 | Class II | Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/ml, 2mL Single Dose Vial, Rx Only, Mfd. by… | Dec 7, 2020 |
| D-0101-2021 | Class II | Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/mL, 2mL Single Dose Vial, Preservative Free, For… | Nov 3, 2020 |
| D-1533-2020 | Class II | Buprenorphine HCl Injection, 0.3 mg/mL, 1 mL vial, For Intramuscular or Intravenous Use Only, Rx… | Aug 14, 2020 |
| D-1308-2020 | Class II | Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie… | Jun 11, 2020 |
| D-1309-2020 | Class II | Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie… | Jun 11, 2020 |
| D-0801-2020 | Class III | methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by: HIKMA… | Jan 14, 2020 |
| D-0864-2020 | Class I | Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL Single Dose Vials (NDC… | Dec 17, 2019 |
Recent FDA Inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jul 13, 2026 | Berkeley Heights, NJ | Drugs | Voluntary Action Indicated (VAI) | 3017452050 |
| May 13, 2026 | Cherry Hill, NJ | Drugs | No Action Indicated (NAI) | 2220525 |
| Apr 30, 2026 | Columbus, OH | Drugs | No Action Indicated (NAI) | 1510690 |
| Jan 17, 2025 | Columbus, OH | Drugs | No Action Indicated (NAI) | 1510690 |
| Jul 23, 2024 | Columbus, OH | Devices | No Action Indicated (NAI) | 1510690 |
| Jun 12, 2024 | Cherry Hill, NJ | Drugs | Voluntary Action Indicated (VAI) | 2220525 |
| Nov 3, 2023 | Cherry Hill, NJ | Drugs | Voluntary Action Indicated (VAI) | 2220525 |
| Sep 29, 2023 | Bedford, OH | Drugs | Voluntary Action Indicated (VAI) | 3012279857 |
| Dec 15, 2022 | Bedford, OH | Drugs | Voluntary Action Indicated (VAI) | 3012279857 |
| Sep 15, 2022 | Columbus, OH | Drugs | No Action Indicated (NAI) | 1510690 |
| Jul 7, 2022 | Cherry Hill, NJ | Drugs | No Action Indicated (NAI) | 2220525 |
| Feb 7, 2022 | Bedford, OH | Drugs | Voluntary Action Indicated (VAI) | 3012279857 |
| Jan 31, 2020 | Bedford, OH | Drugs | Voluntary Action Indicated (VAI) | 3012279857 |
| Nov 22, 2019 | Columbus, OH | Drugs | No Action Indicated (NAI) | 1510690 |
| Sep 10, 2019 | Cherry Hill, NJ | Drugs | Voluntary Action Indicated (VAI) | 2220525 |
| Apr 16, 2019 | Columbus, OH | Drugs | No Action Indicated (NAI) | 1510690 |
| Feb 1, 2019 | Eatontown, NJ | Drugs | No Action Indicated (NAI) | 2250102 |
| Sep 14, 2018 | Cherry Hill, NJ | Drugs | No Action Indicated (NAI) | 2220525 |
| Apr 18, 2018 | Columbus, OH | Drugs | Voluntary Action Indicated (VAI) | 1510690 |
| Apr 13, 2018 | Eatontown, NJ | Drugs | No Action Indicated (NAI) | 2250102 |